CliffBio
small molecule

CLOPIDOGREL BISULFATE

CLOPIDOGREL BISULFATE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameCLOPIDOGREL BISULFATE
Active ingredientCLOPIDOGREL BISULFATE
StrengthEQ 300MG BASE
Dosage formTABLET
RouteORAL
ModalitySmall molecule
FDA approvalMarch 2014
Marketing statusRX

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.